2022 - Research.com Neuroscience in Finland Leader Award
Juha O. Rinne focuses on Internal medicine, Endocrinology, Pathology, Parkinson's disease and Alzheimer's disease. His biological study spans a wide range of topics, including Temporal cortex and Cardiology. His study looks at the intersection of Endocrinology and topics like Thalamus with Radioligand.
Juha O. Rinne focuses mostly in the field of Pathology, narrowing it down to matters related to Positron emission tomography and, in some cases, Statistical parametric mapping and Magnetic resonance imaging. His Parkinson's disease research incorporates elements of Central nervous system disease, Neuroscience and Neuron. His Alzheimer's disease research integrates issues from Biomarker, Prospective cohort study, Posterior cingulate and Cognitive impairment.
Juha O. Rinne mainly focuses on Internal medicine, Endocrinology, Pathology, Parkinson's disease and Dementia. His study in Putamen, Dopamine, Caudate nucleus, Alzheimer's disease and Striatum is carried out as part of his studies in Internal medicine. Juha O. Rinne works mostly in the field of Endocrinology, limiting it down to topics relating to Temporal cortex and, in certain cases, Hippocampus, as a part of the same area of interest.
The Pathology study combines topics in areas such as Positron emission tomography and In vivo. His research in Parkinson's disease intersects with topics in Central nervous system disease and Neuroscience. His study on Dementia also encompasses disciplines like
His primary scientific interests are in Internal medicine, Dementia, Cognition, Endocrinology and Positron emission tomography. His studies link Thalamus with Internal medicine. His Dementia research integrates issues from Neuroimaging, Body mass index, Effects of sleep deprivation on cognitive performance and Cohort.
In general Endocrinology, his work in Insulin is often linked to Carfentanil linking many areas of study. His research integrates issues of Hazard ratio, Survival analysis and Cerebrospinal fluid, Pathology in his study of Positron emission tomography. In his research on the topic of Pathology, Diffusion MRI is strongly related with Pet imaging.
The scientist’s investigation covers issues in Internal medicine, Dementia, Pathology, Positron emission tomography and Cohort study. Internal medicine connects with themes related to Endocrinology in his study. His Dementia study integrates concerns from other disciplines, such as Body mass index, Effects of sleep deprivation on cognitive performance, Cognition and Cohort.
The concepts of his Pathology study are interwoven with issues in White matter, Pons and In vivo. His Positron emission tomography research includes elements of Disease, Diagnostic classification and Control subjects. His studies in Alzheimer's disease integrate themes in fields like Cannabinoid receptor antagonist and Hippocampus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
C-11-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O Rinne;David J Brooks;Martin N Rossor;Nick C Fox.
Lancet Neurology (2010)
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.
T Pohjalainen;J O Rinne;K Någren;P Lehikoinen.
Molecular Psychiatry (1998)
Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.
Petri Luoma;Atle Melberg;Juha O Rinne;Jyrki A Kaukonen.
The Lancet (2004)
Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
A. Okello;J. Koivunen;P. Edison;H. A. Archer.
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease
P. M. Mattila;J. O. Rinne;H. Helenius;D. W. Dickson.
Acta Neuropathologica (2000)
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra.
Rinne Jo;Rummukainen J;Paljärvi L;Rinne Uk.
Annals of Neurology (1989)
Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
P Edison;C C Rowe;J O Rinne;S Ng.
Journal of Neurology, Neurosurgery, and Psychiatry (2008)
Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.
Valtteri Kaasinen;Harry Vilkman;Jarmo Hietala;Kjell Någren.
Neurobiology of Aging (2000)
Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
Juha O. Rinne;Raija Portin;Hanna Ruottinen;Elina Nurmi.
JAMA Neurology (2000)
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: